Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants. Jaumdally, S., Tomasicchio, M., Pooran, A., Esmail, A., Kotze, A., Meier, S., Wilson, L., Oelofse, S., Van Der Merwe, C., Roomaney, A., Davids, M., Suliman, T., Joseph, R., Perumal, T., Scott, A., Shaw, M., Preiser, W., Williamson, C., Goga, A., Mayne, E., Gray, G., Moore, P., Sigal, A., Limberis, J., Metcalfe, J., & Dheda, K. Nature Communications, 15(1):2003, March, 2024. ![Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Abstract Airborne transmission of SARS-CoV-2 aerosol remains contentious. Importantly, whether cough or breath-generated bioaerosols can harbor viable and replicating virus remains largely unclarified. We performed size-fractionated aerosol sampling (Andersen cascade impactor) and evaluated viral culturability in human cell lines (infectiousness), viral genetics, and host immunity in ambulatory participants with COVID-19. Sixty-one percent (27/44) and 50% (22/44) of participants emitted variant-specific culture-positive aerosols \textless10μm and \textless5μm, respectively, for up to 9 days after symptom onset. Aerosol culturability is significantly associated with lower neutralizing antibody titers, and suppression of transcriptomic pathways related to innate immunity and the humoral response. A nasopharyngeal Ct \textless17 rules-in ~40% of aerosol culture-positives and identifies those who are probably highly infectious. A parsimonious three transcript blood-based biosignature is highly predictive of infectious aerosol generation (PPV \textgreater 95%). There is considerable heterogeneity in potential infectiousness i.e., only 29% of participants were probably highly infectious (produced culture-positive aerosols \textless5μm at ~6 days after symptom onset). These data, which comprehensively confirm variant-specific culturable SARS-CoV-2 in aerosol, inform the targeting of transmission-related interventions and public health containment strategies emphasizing improved ventilation.
@article{jaumdally_frequency_2024,
title = {Frequency, kinetics and determinants of viable {SARS}-{CoV}-2 in bioaerosols from ambulatory {COVID}-19 patients infected with the {Beta}, {Delta} or {Omicron} variants},
volume = {15},
issn = {2041-1723},
url = {https://www.nature.com/articles/s41467-024-45400-1},
doi = {10.1038/s41467-024-45400-1},
abstract = {Abstract
Airborne transmission of SARS-CoV-2 aerosol remains contentious. Importantly, whether cough or breath-generated bioaerosols can harbor viable and replicating virus remains largely unclarified. We performed size-fractionated aerosol sampling (Andersen cascade impactor) and evaluated viral culturability in human cell lines (infectiousness), viral genetics, and host immunity in ambulatory participants with COVID-19. Sixty-one percent (27/44) and 50\% (22/44) of participants emitted variant-specific culture-positive aerosols {\textless}10μm and {\textless}5μm, respectively, for up to 9 days after symptom onset. Aerosol culturability is significantly associated with lower neutralizing antibody titers, and suppression of transcriptomic pathways related to innate immunity and the humoral response. A nasopharyngeal Ct {\textless}17 rules-in {\textasciitilde}40\% of aerosol culture-positives and identifies those who are probably highly infectious. A parsimonious three transcript blood-based biosignature is highly predictive of infectious aerosol generation (PPV {\textgreater} 95\%). There is considerable heterogeneity in potential infectiousness i.e., only 29\% of participants were probably highly infectious (produced culture-positive aerosols {\textless}5μm at {\textasciitilde}6 days after symptom onset). These data, which comprehensively confirm variant-specific culturable SARS-CoV-2 in aerosol, inform the targeting of transmission-related interventions and public health containment strategies emphasizing improved ventilation.},
language = {en},
number = {1},
urldate = {2025-06-24},
journal = {Nature Communications},
author = {Jaumdally, S. and Tomasicchio, M. and Pooran, A. and Esmail, A. and Kotze, A. and Meier, S. and Wilson, L. and Oelofse, S. and Van Der Merwe, C. and Roomaney, A. and Davids, M. and Suliman, T. and Joseph, R. and Perumal, T. and Scott, A. and Shaw, M. and Preiser, W. and Williamson, C. and Goga, A. and Mayne, E. and Gray, G. and Moore, P. and Sigal, A. and Limberis, J. and Metcalfe, J. and Dheda, K.},
month = mar,
year = {2024},
pages = {2003},
}
Downloads: 0
{"_id":"Gn3iPJ3aYGFsPd6D8","bibbaseid":"jaumdally-tomasicchio-pooran-esmail-kotze-meier-wilson-oelofse-etal-frequencykineticsanddeterminantsofviablesarscov2inbioaerosolsfromambulatorycovid19patientsinfectedwiththebetadeltaoromicronvariants-2024","author_short":["Jaumdally, S.","Tomasicchio, M.","Pooran, A.","Esmail, A.","Kotze, A.","Meier, S.","Wilson, L.","Oelofse, S.","Van Der Merwe, C.","Roomaney, A.","Davids, M.","Suliman, T.","Joseph, R.","Perumal, T.","Scott, A.","Shaw, M.","Preiser, W.","Williamson, C.","Goga, A.","Mayne, E.","Gray, G.","Moore, P.","Sigal, A.","Limberis, J.","Metcalfe, J.","Dheda, K."],"bibdata":{"bibtype":"article","type":"article","title":"Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants","volume":"15","issn":"2041-1723","url":"https://www.nature.com/articles/s41467-024-45400-1","doi":"10.1038/s41467-024-45400-1","abstract":"Abstract Airborne transmission of SARS-CoV-2 aerosol remains contentious. Importantly, whether cough or breath-generated bioaerosols can harbor viable and replicating virus remains largely unclarified. We performed size-fractionated aerosol sampling (Andersen cascade impactor) and evaluated viral culturability in human cell lines (infectiousness), viral genetics, and host immunity in ambulatory participants with COVID-19. Sixty-one percent (27/44) and 50% (22/44) of participants emitted variant-specific culture-positive aerosols \\textless10μm and \\textless5μm, respectively, for up to 9 days after symptom onset. Aerosol culturability is significantly associated with lower neutralizing antibody titers, and suppression of transcriptomic pathways related to innate immunity and the humoral response. A nasopharyngeal Ct \\textless17 rules-in ~40% of aerosol culture-positives and identifies those who are probably highly infectious. A parsimonious three transcript blood-based biosignature is highly predictive of infectious aerosol generation (PPV \\textgreater 95%). There is considerable heterogeneity in potential infectiousness i.e., only 29% of participants were probably highly infectious (produced culture-positive aerosols \\textless5μm at ~6 days after symptom onset). These data, which comprehensively confirm variant-specific culturable SARS-CoV-2 in aerosol, inform the targeting of transmission-related interventions and public health containment strategies emphasizing improved ventilation.","language":"en","number":"1","urldate":"2025-06-24","journal":"Nature Communications","author":[{"propositions":[],"lastnames":["Jaumdally"],"firstnames":["S."],"suffixes":[]},{"propositions":[],"lastnames":["Tomasicchio"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Pooran"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Esmail"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Kotze"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Meier"],"firstnames":["S."],"suffixes":[]},{"propositions":[],"lastnames":["Wilson"],"firstnames":["L."],"suffixes":[]},{"propositions":[],"lastnames":["Oelofse"],"firstnames":["S."],"suffixes":[]},{"propositions":[],"lastnames":["Van","Der","Merwe"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["Roomaney"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Davids"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Suliman"],"firstnames":["T."],"suffixes":[]},{"propositions":[],"lastnames":["Joseph"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Perumal"],"firstnames":["T."],"suffixes":[]},{"propositions":[],"lastnames":["Scott"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Shaw"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Preiser"],"firstnames":["W."],"suffixes":[]},{"propositions":[],"lastnames":["Williamson"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["Goga"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Mayne"],"firstnames":["E."],"suffixes":[]},{"propositions":[],"lastnames":["Gray"],"firstnames":["G."],"suffixes":[]},{"propositions":[],"lastnames":["Moore"],"firstnames":["P."],"suffixes":[]},{"propositions":[],"lastnames":["Sigal"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Limberis"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Metcalfe"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Dheda"],"firstnames":["K."],"suffixes":[]}],"month":"March","year":"2024","pages":"2003","bibtex":"@article{jaumdally_frequency_2024,\n\ttitle = {Frequency, kinetics and determinants of viable {SARS}-{CoV}-2 in bioaerosols from ambulatory {COVID}-19 patients infected with the {Beta}, {Delta} or {Omicron} variants},\n\tvolume = {15},\n\tissn = {2041-1723},\n\turl = {https://www.nature.com/articles/s41467-024-45400-1},\n\tdoi = {10.1038/s41467-024-45400-1},\n\tabstract = {Abstract \n Airborne transmission of SARS-CoV-2 aerosol remains contentious. Importantly, whether cough or breath-generated bioaerosols can harbor viable and replicating virus remains largely unclarified. We performed size-fractionated aerosol sampling (Andersen cascade impactor) and evaluated viral culturability in human cell lines (infectiousness), viral genetics, and host immunity in ambulatory participants with COVID-19. Sixty-one percent (27/44) and 50\\% (22/44) of participants emitted variant-specific culture-positive aerosols {\\textless}10μm and {\\textless}5μm, respectively, for up to 9 days after symptom onset. Aerosol culturability is significantly associated with lower neutralizing antibody titers, and suppression of transcriptomic pathways related to innate immunity and the humoral response. A nasopharyngeal Ct {\\textless}17 rules-in {\\textasciitilde}40\\% of aerosol culture-positives and identifies those who are probably highly infectious. A parsimonious three transcript blood-based biosignature is highly predictive of infectious aerosol generation (PPV {\\textgreater} 95\\%). There is considerable heterogeneity in potential infectiousness i.e., only 29\\% of participants were probably highly infectious (produced culture-positive aerosols {\\textless}5μm at {\\textasciitilde}6 days after symptom onset). These data, which comprehensively confirm variant-specific culturable SARS-CoV-2 in aerosol, inform the targeting of transmission-related interventions and public health containment strategies emphasizing improved ventilation.},\n\tlanguage = {en},\n\tnumber = {1},\n\turldate = {2025-06-24},\n\tjournal = {Nature Communications},\n\tauthor = {Jaumdally, S. and Tomasicchio, M. and Pooran, A. and Esmail, A. and Kotze, A. and Meier, S. and Wilson, L. and Oelofse, S. and Van Der Merwe, C. and Roomaney, A. and Davids, M. and Suliman, T. and Joseph, R. and Perumal, T. and Scott, A. and Shaw, M. and Preiser, W. and Williamson, C. and Goga, A. and Mayne, E. and Gray, G. and Moore, P. and Sigal, A. and Limberis, J. and Metcalfe, J. and Dheda, K.},\n\tmonth = mar,\n\tyear = {2024},\n\tpages = {2003},\n}\n\n\n\n","author_short":["Jaumdally, S.","Tomasicchio, M.","Pooran, A.","Esmail, A.","Kotze, A.","Meier, S.","Wilson, L.","Oelofse, S.","Van Der Merwe, C.","Roomaney, A.","Davids, M.","Suliman, T.","Joseph, R.","Perumal, T.","Scott, A.","Shaw, M.","Preiser, W.","Williamson, C.","Goga, A.","Mayne, E.","Gray, G.","Moore, P.","Sigal, A.","Limberis, J.","Metcalfe, J.","Dheda, K."],"key":"jaumdally_frequency_2024","id":"jaumdally_frequency_2024","bibbaseid":"jaumdally-tomasicchio-pooran-esmail-kotze-meier-wilson-oelofse-etal-frequencykineticsanddeterminantsofviablesarscov2inbioaerosolsfromambulatorycovid19patientsinfectedwiththebetadeltaoromicronvariants-2024","role":"author","urls":{"Paper":"https://www.nature.com/articles/s41467-024-45400-1"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero-group/Yulisha27/6024450","dataSources":["Krmt6gt9ktB2s6ARh","PNS53NAAhKDwHWBCi"],"keywords":[],"search_terms":["frequency","kinetics","determinants","viable","sars","cov","bioaerosols","ambulatory","covid","patients","infected","beta","delta","omicron","variants","jaumdally","tomasicchio","pooran","esmail","kotze","meier","wilson","oelofse","van der merwe","roomaney","davids","suliman","joseph","perumal","scott","shaw","preiser","williamson","goga","mayne","gray","moore","sigal","limberis","metcalfe","dheda"],"title":"Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants","year":2024}